CherryPURE® is supported by multiple human clinical trials*

1. Effects of powdered Montmorency tart cherry supplementation on an acute bout of intense lower body strength exercise in resistance-trained males

Led by Dr. Richard Kreider from the Department of Health and Kinesiology, Exercise and Sport Nutrition Laboratory, in College Station, TX, the research team used a well-established double-blind, placebo-controlled testing method to examine if short-term ingestion of a powdered tart cherry supplement, before, and following intense resistance-exercise alleviates muscle soreness and recovery from strength loss.

2. Effects of powdered Montmorency Tart Cherry supplementation on acute endurance exercise performance in aerobically trained individuals

Results revealed that short-term supplementation of Montmorency powdered tart cherries surrounding an endurance challenge attenuated markers of muscle catabolism, reduced immune and inflammatory stress, better maintained redox balance, and increased performance in aerobically trained individuals.

3. Acute Ingestion of Montmorency Tart Cherry reduces serum uric acid but has no Impact on High Sensitivity C-Reactive Protein or Oxidative Capacity

Led by Dr. Angela Hillman from the School of Applied Health Sciences and Wellness at Ohio University, the research team worked with forty-eight individuals to assess the efficacy of Montmorency tart cherry servings and juice versus markers of inflammation (Uric Acid), high-sensitivity C-reactive protein (hsCRP) and oxidative capacity (plasma oxygen radical absorbance capacity (ORAC)). Results indicated that a single CherryPURE® 480mg servings is most effective for lowering UA suggested servings may be used by those who do not enjoy the taste of tart cherry juice.